|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS |
aBlood Bank and
dDepartment of Obstetrics and Gynecology, Landspitali-University Hospital, Reykjavík, Iceland;
bInstitute of Immunology, University Hospital, Oslo, Norway;
cBasic Research Program, SAIC-Frederick, Inc., Center for Cancer Research, National Cancer Institute-Frederick, NIH, Frederick, Maryland, USA;
eIceland Genomics Corporation, Reykjavík, Iceland
Key Words. Human • Hematopoietic progenitor cells • Embryonic stem cells • Gene expression
Correspondence: Kristbjorn Orri Gudmundsson, Ph.D., Cancer and Developmental Biology Laboratory, Center for Cancer Research, National Cancer Institute–Frederick, Maryland, USA. Telephone: 301-846-1509; Fax: 301-846-7042; e-mail: orri{at}ncifcrf.gov
Received September 29, 2006;
accepted for publication February 13, 2007.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS February 22, 2007.
Inducible hematopoietic stem/progenitor cell lines represent a model for studying genes involved in self-renewal and differentiation. Here, gene expression was studied in the inducible human CD34+ acute myelogenous leukemia cell line KG1 using oligonucleotide arrays and suppression subtractive cloning. Using this approach, we identified Dlg7, the homolog of the Drosophila Dlg1 tumor suppressor gene, as downregulated at the early stages of KG1 differentiation. Similarly, Dlg7 was expressed in normal purified umbilical cord blood CD34+CD38– progenitors but not in the more committed CD34+CD38+ population. Dlg7 expression was not detected in differentiated cells obtained from hematopoietic colonies, nor was expression detected in purified T-cells, B-cells, and monocytes. When analyzed in different types of stem cells, Dlg7 expression was detected in purified human bone marrow-derived CD133+ progenitor cells, human mesenchymal stem cells, and mouse embryonic stem (ES) cells. Overexpression of Dlg7 in mouse ES cells increased their growth rate and reduced the number of EBs emerging upon differentiation. In addition, the EBs were significantly smaller, indicating an inhibition in differentiation. This inhibition was further supported by higher expression of Bmp4, Oct4, Rex1, and Nanog in EBs overexpressing Dlg7 and lower expression of Brachyury. Finally, the Dlg7 protein was detected in liver and colon carcinoma tumors but not in normal adjacent tissues, suggesting a role for the gene in carcinogenesis. In conclusion, our results suggest that Dlg7 has a role in stem cell survival, in maintaining stem cell properties, and in carcinogenesis.
This article has been cited by other articles:
![]() |
F. Perugi, D. Muriaux, B. C. Ramirez, S. Chabani, E. Decroly, J.-L. Darlix, V. Blot, and C. Pique Human Discs Large Is a New Negative Regulator of Human Immunodeficiency Virus-1 Infectivity Mol. Biol. Cell, January 1, 2009; 20(1): 498 - 508. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
